03:31 AM EDT, 08/12/2024 (MT Newswires) -- Mark L. Jacobson, Chief Operating Officer, on August 09, 2024, sold 47,739 shares in Axsome Therapeutics ( AXSM ) for $4,022,488. Following the Form 4 filing with the SEC, Jacobson has control over a total of 5,783 shares of the company, with 5,783 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1579428/000095017024094967/xslF345X03/ownership.xml

Price: 79.59, Change: -3.50, Percent Change: -4.21